The PE Ratio as of December 2024 (TTM) for IntelGenx Technologies Corp. (IGXT) is -2.83

According to IntelGenx Technologies Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -2.83. This represents a change of -0.42% compared to the average of -2.84 of the last 4 quarters.

IntelGenx Technologies Corp. (IGXT) Historical PE Ratio (quarterly & annually)

How has IGXT PE Ratio performed in the past?

The mean historical PE Ratio of IntelGenx Technologies Corp. over the last ten years is -7.36. The current -2.83 PE Ratio has changed 3.74% with respect to the historical average. Over the past ten years (40 quarters), IGXT's PE Ratio was at its highest in in the September 2016 quarter at 400.01. The PE Ratio was at its lowest in in the March 2015 quarter at -188.05.

IntelGenx Technologies Corp. (IGXT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of IntelGenx Technologies Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IntelGenx Technologies Corp. (IGXT) Average PE Ratio

How has IGXT PE Ratio performed in the past?

The current PE Ratio of IntelGenx Technologies Corp. (IGXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IntelGenx Technologies Corp. (IGXT) PE Ratio vs. Peers

How is IGXT’s PE Ratio compared to its peers?

IntelGenx Technologies Corp.’s PE Ratio is less than Adynxx, Inc. (0), less than NLS Pharmaceutics AG (0), greater than Ascletis Pharma Inc. (-38.93), greater than Sirona Biochem Corp. (-11.50), greater than LianBio (-6.37), less than Fennec Pharmaceuticals Inc. (0), less than Larimar Therapeutics, Inc. (-0.75), greater than Verrica Pharmaceuticals Inc. (-140.49), greater than Homology Medicines, Inc. (-3.72), less than Candel Therapeutics, Inc. (-0.38), less than PMV Pharmaceuticals, Inc. (-0.01), greater than Acurx Pharmaceuticals, Inc. (-5.40), less than Monopar Therapeutics Inc. (-1.47), less than Enochian Biosciences, Inc. (-0.01), less than Connect Biopharma Holdings Limited (-0.59), less than Acumen Pharmaceuticals, Inc. (-1.98), less than Eton Pharmaceuticals, Inc. (7.21), less than Nuvation Bio Inc. (-1.32), greater than Eledon Pharmaceuticals, Inc. (-59.82), less than null (-1.45), less than null (18.27),

Build a custom stock screener for IntelGenx Technologies Corp. (IGXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntelGenx Technologies Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IntelGenx Technologies Corp. (IGXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IntelGenx Technologies Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.